The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.

Embryonal renal mesenchyme contains pluripotent progenitor cells characterized by expression of SIX2, which suppresses cellular differentiation. Additionally hypomethylation of the promotor region in renal neoplasms indicates a role of SIX2 in tumorigenesis. This study focuses therefore on the investigation of SIX2 in different renal neoplasms and the mode and consequences of SIX2 activation. Expression of SIX2 was determined in renal cell carcinomas, nephroblastomas, and dysplastic kidneys using immunohistochemistry and quantitative real-time polymerase chain reaction. Its potential mode of activation was assessed by measuring upstream activators by quantitative real-time polymerase chain reaction and the level of methylation of the promoter region by quantitative DNA methylation analysis. Consequences of SIX2 activation were investigated by overexpressing SIX2 in a cell line. Forty-seven of 49 renal clear cell carcinomas showed nuclear staining of SIX2, whereas all papillary carcinomas were negative. In nephroblastomas of various subtypes blastema showed a significant up-regulation (P < .01) and a strong nuclear protein expression of SIX2 in contrast to negative epithelial and mesenchymal areas. 11 cases of dysplastic kidneys were entirely negative. Upstream activators of SIX2 indicated an activation of the signal transduction pathway in most samples. No difference of promoter methylation status was observed between blastema and epithelial structures. A significantly higher percentage of cells in the S-phase and an increased migration were detected in the cell-line overexpressing SIX2. Our study suggests that activation of SIX2 might contribute to the pathogenesis of renal clear cell carcinomas and nephroblastomas. SIX2 also appears to be a valuable marker for minimal residual blastema contributing to the prognosis of nephroblastomas.

[1]  Q. Al-Awqati,et al.  Stem cells in the kidney. , 2002, Kidney international.

[2]  D. Jacqmin,et al.  LIM-class homeobox gene Lim1, a novel oncogene in human renal cell carcinoma , 2011, Oncogene.

[3]  P. Voûte,et al.  Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  Sanjay Jain,et al.  Expression profiles of congenital renal dysplasia reveal new insights into renal development and disease , 2007, Pediatric Nephrology.

[5]  L. Saxén,et al.  Early organogenesis of the kidney , 1987, Pediatric Nephrology.

[6]  N. Kaminski,et al.  Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is accompanied by a profile of gene expression similar to normal human kidney development. , 2002, Journal of the American Society of Nephrology : JASN.

[7]  C. Boland,et al.  Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. , 2010, Cancer research.

[8]  E. J. Neves,et al.  Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset , 2011, Cell Death and Disease.

[9]  Norman Breslow,et al.  Subsets of Very Low Risk Wilms Tumor Show Distinctive Gene Expression, Histologic, and Clinical Features , 2009, Clinical Cancer Research.

[10]  K. Reidy,et al.  Cell and molecular biology of kidney development. , 2009, Seminars in nephrology.

[11]  Diogo F. C. Patrão,et al.  Molecular Profiling of Isolated Histological Components of Wilms Tumor Implicates a Common Role for the Wnt Signaling Pathway in Kidney and Tumor Development , 2008, Oncology.

[12]  A. McMahon,et al.  Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. , 2008, Cell stem cell.

[13]  A. Bakkaloğlu,et al.  SIX2 and BMP4 mutations associate with anomalous kidney development. , 2008, Journal of the American Society of Nephrology : JASN.

[14]  G. Dressler.  Pax-2, kidney development, and oncogenesis. , 1996, Medical and pediatric oncology.

[15]  V. Huff.  Wilms tumor genetics. , 1998, American journal of medical genetics.

[16]  G. Almeida-Porada,et al.  Differences amid bone marrow and cord blood hematopoietic stem/progenitor cell division kinetics , 2009, Journal of cellular physiology.

[17]  I M Morison,et al.  Canonical WNT signalling determines lineage specificity in Wilms tumour , 2009, Oncogene.

[18]  David J. Anderson,et al.  Regulatory Mechanisms in Stem Cell Biology , 1997, Cell.

[19]  R. Oosterom,et al.  Kidneys and urinary tract , 1995 .

[20]  Wan Ariffin Bin Abdullah,et al.  Med Pediatr Oncol , 1999 .

[21]  J. Beckwith,et al.  Ultrastructure and histogenesis of the renal tumors of childhood: an overview. , 1987, Ultrastructural pathology.

[22]  R. Nishinakamura.  Stem cells in the embryonic kidney. , 2008, Kidney international.

[23]  Charles A Powell,et al.  Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. , 2002, The American journal of pathology.

[24]  I. Leuschner,et al.  Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes , 2006, Virchows Archiv.

[25]  G. Dressler,et al.  Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney , 2006, The EMBO journal.

[26]  G. Rechavi,et al.  Accumulation of Malignant Renal Stem Cells Is Associated with Epigenetic Changes in Normal Renal Progenitor Genes , 2008, Stem cells.

[27]  M. Gessler,et al.  Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor , 2010, Clinical Cancer Research.

[28]  G. Dressler.  The cellular basis of kidney development. , 2006, Annual review of cell and developmental biology.

[29]  J. Karlsson,et al.  SIX1 protein expression selectively identifies blastemal elements in Wilms tumor , 2012, Pediatric blood & cancer.

[30]  H. Moch,et al.  Genetic progression of renal cell carcinoma , 2002, Virchows Archiv.

[31]  I. Leuschner,et al.  Lim1, an Embryonal Transcription Factor, Is Absent in Multicystic Renal Dysplasia, but Reactivated in Nephroblastomas , 2011, Pathobiology.

[32]  A. McMahon,et al.  Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. , 2005, Developmental cell.

[33]  G. Dressler,et al.  A Hox-Eya-Pax Complex Regulates Early Kidney Developmental Gene Expression , 2007, Molecular and Cellular Biology.

[34]  N. Amariglio,et al.  Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population , 2009, Journal of cellular and molecular medicine.

[35]  N Breslow,et al.  Epidemiology of Wilms tumor. , 1993, Medical and pediatric oncology.